{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:39:36Z","timestamp":1781192376710,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":1399,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.14338\/ijpt-19-00077.1","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T18:54:25Z","timestamp":1588013665000},"page":"11-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Bradford S.","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond B. Mailhot","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Slayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Katzenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Flampouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14338\/IJPT-19-00077.1_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1200\/JCO.1984.2.2.80","article-title":"Childhood Hodgkin's disease: patterns of relapse","volume":"2","author":"Russell","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib2","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.2012.5847","article-title":"Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma","volume":"307","author":"Metzger","year":"2012","journal-title":"JAMA"},{"key":"10.14338\/IJPT-19-00077.1_bib3","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2014.10.042","article-title":"Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group","volume":"92","author":"Dharmarajan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-19-00077.1_bib5","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1200\/JCO.2014.57.8138","article-title":"Randomized phase III trial comparing ABVD plus radiotherapy with the Stanford V regimen in patients with stages I or II locally extensive, bulky mediastinal Hodgkin lymphoma: a subset analysis of the North American intergroup E2496 trial","volume":"33","author":"Advani","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.prro.2014.05.003","article-title":"Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: guidelines from the International Lymphoma Radiation Oncology Group","volume":"5","author":"Hodgson","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamaoncol.2015.4794","article-title":"Radiation Therapy for Hodgkin lymphoma\u2014can it be administered more safely if necessary?","volume":"2","author":"Straus","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib8","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/pbc.26044","article-title":"Proton therapy for pediatric Hodgkin lymphoma","volume":"63","author":"Wray","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.14338\/IJPT-19-00077.1_bib9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1200\/JCO.18.01764","article-title":"Therapy-related cardiac risk in childhood cancer survivors: an analysis of the childhood cancer survivor study","volume":"37","author":"Bates","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib10","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/j.prro.2018.01.007","article-title":"Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest","volume":"8","author":"Lewis","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.adro.2017.03.001","article-title":"Effects of vertebral-body-sparing proton craniospinal irradiation on the spine of young pediatric patients with medulloblastoma","volume":"2","author":"MacEwan","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"key":"10.14338\/IJPT-19-00077.1_bib13","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2015.01.048","article-title":"Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group","volume":"92","author":"Kriz","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-19-00077.1_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2017.05.004","article-title":"Evidence-based review on the use of proton therapy in lymphoma from the Particle Therapy Cooperative Group (PTCOG) lymphoma subcommittee","volume":"99","author":"Tseng","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-19-00077.1_bib16","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/annonc\/mdx287","article-title":"Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma","volume":"28","author":"Hoppe","year":"2017","journal-title":"Ann Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13014-018-1003-4","article-title":"TEDDI: radiotherapy delivery in deep inspiration for pediatric patients\u2014a NOPHO feasibility study","volume":"13","author":"Lundgaard","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.14338\/IJPT-19-00077.1_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jamaoncol.2018.5911","article-title":"Association of combined modality therapy vs chemotherapy alone with overall survival in early-stage pediatric hodgkin lymphoma","volume":"5","author":"Jhawar","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.14338\/IJPT-19-00077.1_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00066-012-0235-8","article-title":"Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?","volume":"189","author":"Knausl","year":"2013","journal-title":"Strahlenther Onkol"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/6\/4\/11\/2512655\/i2331-5180-6-4-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/6\/4\/11\/2512655\/i2331-5180-6-4-11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:32:48Z","timestamp":1762421568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518023001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2331518023001476"],"URL":"https:\/\/doi.org\/10.14338\/ijpt-19-00077.1","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14338\/IJPT-19-00077.1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 \u00a9 2020 THE AUTHORS. Published by Elsevier BV on behalf of the Particle Therapy Co-operative Group. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}